MedTrace Logo

A Trial of SHR8735 in Healthy Subjects

NCT04701216 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-11-09

No results posted yet for this study

Summary

This is a phase 1 open-label study.

Conditions

  • Healthy Volunteers

Interventions

DRUG

SHR8735

SHR8735 is an thrombopoietin receptor agonist to promote platelet production.

Sponsors & Collaborators

  • Atridia Pty Ltd.

    lead INDUSTRY

Principal Investigators

  • Ana Sun, Dr · Study Principal Investigator

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2021-07-15
Completion
2021-07-15

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04701216 on ClinicalTrials.gov